foxo4-dri senolytic peptide human trial 2024 2025

foxo4-dri senolytic peptide human trial 2024 2025 Frontiers Peptide Inhibitors Targeting FOXO4-p53 Interactions

Name: foxo4-dri senolytic peptide human trial 2024 2025 Frontiers Peptide Inhibitors Targeting FOXO4-p53 Interactions
Brand: www.marsberger-treibhaus.de
SKU: 58795028012
Price: 25.94 USD
Availability: InStock
Rating: 4.3258 (12 reviews)

Peptide Inhibitors Targeting FOXO4 p53 Interactions and Inducing Senescent Cancer Cell specific Apoptosis Journal of Medicinal Chemistry Senescent cells as a target for anti aging interventions: From senolytics to immune therapies PMC CHK2 USP37 axis stabilizes FOXO4 to sustain senescence and evade apoptosis PNAS Senolytic Interventions for Type 2 Diabetes: Current Evidence and Future Directions

SKU: 58795028012 · From www.marsberger-treibhaus.de

4.3

USD25.94 USD75.94

Pay in 4 interest-free payments of $6.49 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Jul 30 - Aug 4

Description

Landmark 2017 Cell paper One of the foundational studies (by Baar et al.) was titled Targeted apoptosis of senescent cells restores tissue homeostasis in response to chemotoxicity and aging. This work demonstrated: In mice that were aged or given chemotherapy (accelerated ageing), treatment with FOXO4-DRI improved physical performance, fur quality, and renal function